Hua Medicine Announces 2023 Interim Results

Hua Medicine Announces 2023 Interim Results

Related Keywords

United States ,China ,Shanghai ,Chinese ,American ,Li Chen ,Zhejiang Raybow ,China National Reimbursement Drug List ,Chinese University Of Hong Kong ,Progress Of Clinical Research ,National Reimbursement Drug List ,Company Operations ,National Healthcare Security Administration ,National Medical Products Administration ,American Diabetes Association ,Hua Medicine The Company ,Nature Communications ,Hua Medicine ,Changzhou Syntheall ,Shanghai Desano ,Investigational New Drug ,Clinical Research ,Diabetes Association ,Chinese University ,Hong Kong ,